I et andet 12- ugers forsøg var forekomsten af EPS 26, 6% for aripiprazol- behandlende patienter og 17, 6% for patienter lithium - behandlede patienter.
In another 12-week trial, the incidence of EPS was 26.6% for patients treated with aripiprazole and 17.6% for those treated with lithium.